SCHEMBL15824972

SCHEMBL15824972

CCN(C)c1ccc2ncncc2c1

nearest known ligand 0.71

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 9/20 0.71
▸ PIK3CD O00329 2/20 0.45
▸ PIK3CA P42336 2/20 0.45
▸ FGFR4 P22455 1/20 0.40
▸ AR P10275 1/20 0.39
▸ OPRM1 P35372 1/20 0.36
▸ OPRL1 P41146 1/20 0.36
▸ TDO2 P48775 1/20 0.36
▸ PSMB5 P28074 2/20 0.36
▸ TERT O14746 1/20 0.35
▸ BRAF P15056 1/20 0.34
▸ PIK3CB P42338 1/20 0.34
▸ PI4KA P42356 1/20 0.34
▸ PIK3CG P48736 1/20 0.34
▸ PI4KB Q9UBF8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15825796 0.83 EGFR (1.00) EGFRPIK3CDPIK3CAFGFR4TDO2
SCHEMBL9776814 0.73 EGFR (0.55) EGFRPIK3CDPIK3CAFGFR4AR
SCHEMBL30918007 0.73 EGFR (0.55) EGFRPIK3CDPIK3CAFGFR4AR
SCHEMBL17376120 0.72 NTSR1 (0.48) EGFRPSMB5
SCHEMBL28243443 0.70 EGFR (0.70) EGFRPIK3CDPIK3CAFGFR4
SCHEMBL9971309 0.70 EGFR (0.51) EGFRPIK3CDPIK3CAFGFR4AR
SCHEMBL29985188 0.70 EGFR (0.60) EGFRPIK3CDPIK3CAFGFR4AR
SCHEMBL1771905 0.70 EGFR (0.60) EGFRPIK3CDPIK3CAFGFR4AR
SCHEMBL3098892 0.69 EGFR (0.57) EGFRPIK3CDPIK3CAFGFR4AR
SCHEMBL8644295 0.69 PIK3CA (0.73) EGFRPIK3CDPIK3CAFGFR4AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2938608-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 Sanford-Burnham Medical Research Institute (US) 2015-11-04 — — EP disclosed
WO-2014100501-A1 SMALL MOLECULE AGONISTS OF NEUROTENSIN RECEPTOR 1 SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2014-06-26 — — WO disclosed
Send feedback